CCH-aaes

DRUG3 trials

Sponsors

Endo Pharmaceuticals

Conditions

CelluliteEdematous Fibrosclerotic PanniculopathyEdematous Fibrosclerotic Panniculopathy (EFP)

Phase 2

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks

CompletedNCT05419505

Endo PharmaceuticalsCellulite, Edematous Fibrosclerotic Panniculopathy

Start: 2022-06-15End: 2023-06-21Updated: 2025-03-07

Phase 3

Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

CompletedNCT03526549

Endo PharmaceuticalsCellulite, Edematous Fibrosclerotic Panniculopathy

Start: 2018-04-26End: 2021-10-08Updated: 2023-09-08

Phase 4

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

CompletedNCT04677712

Endo PharmaceuticalsCellulite, Edematous Fibrosclerotic Panniculopathy (EFP)

Start: 2020-12-28End: 2021-09-02Updated: 2023-08-21